Literature DB >> 12201798

Cost effectiveness of asthma management strategies.

Mike Thomas, John Haughney, David Price.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12201798     DOI： 10.2165/00019053-200220110-00008

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  4 in total

Review 1.  The costs of asthma.

Authors:  P J Barnes; B Jonsson; J B Klim
Journal:  Eur Respir J       Date:  1996-04       Impact factor: 16.671

2.  Development of an economic model to assess the cost effectiveness of asthma management strategies.

Authors:  Martin J Price; Andrew H Briggs
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

3.  Noncompliance and treatment failure in children with asthma.

Authors:  H Milgrom; B Bender; L Ackerson; P Bowry; B Smith; C Rand
Journal:  J Allergy Clin Immunol       Date:  1996-12       Impact factor: 10.793

4.  Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devices. EDICI.

Authors:  J Lenney; J A Innes; G K Crompton
Journal:  Respir Med       Date:  2000-05       Impact factor: 3.415
  4 in total
  2 in total

Review 1.  Inhaled salmeterol/fluticasone propionate combination: a pharmacoeconomic review of its use in the management of asthma.

Authors:  Katherine A Lyseng-Williamson; Greg L Plosker
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

2.  Mesenchymal stem cell transfer suppresses airway remodeling in a toluene diisocyanate-induced murine asthma model.

Authors:  Shin-Hwa Lee; An-Soo Jang; Ji-Hee Kwon; Seong-Kyu Park; Jong-Ho Won; Choon-Sik Park
Journal:  Allergy Asthma Immunol Res       Date:  2011-02-17       Impact factor: 5.764
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.